University launches ‘first of its kind’ certification program in healthcare AI

Healthcare professionals looking to raise their AI game have a new chance to do so while earning CME credits as well as certification.

The University of Illinois announced its AI in Medicine Certificate program July 8, saying the course is the first of its kind.

The program presents students with six modules to be taken online. Syllabus items include “Data and decisions,” “Concepts of machine learning” and “Real-world applications of AI in medicine.”

The program’s website says those who complete the course will be equipped to “read literature related to artificial intelligence in medicine, understand how data-driven decisions are made and assessed, identify and define different types of artificial intelligence tools and techniques used in medicine and actively participate in the selection, purchase and deployment of AI-based medical software.”

Total price tag is $750.

Instructors are Kevin Teal, MD, a staff neurosurgeon at Carle Foundation Hospital, and Mark Anastasio, PhD, head of the bioengineering department at the University of Illinois Urbana-Champaign.

Along with the online modules, students will have access to AI experts during weekly virtual office hours.

The program is a joint project of the university’s colleges of medicine, engineering and veterinary medicine.

Announcement here, program website here.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.